for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CureVac BV

5CV.DE

Latest Trade

83.22EUR

Change

-1.32(-1.56%)

Volume

21,182

Today's Range

81.41

 - 

84.00

52 Week Range

37.15

 - 

89.99

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
84.54
Open
84.00
Volume
21,182
3M AVG Volume
11.86
Today's High
84.00
Today's Low
81.41
52 Week High
89.99
52 Week Low
37.15
Shares Out (MIL)
177.97
Market Cap (MIL)
18,241.74
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Curevac 9M Net Loss Down At EUR 71.0 Mln

Saudi's Spimaco Addwaeih Signs MoU With Curevac To Supply COVID-19 Vaccine

Wacker Chemie And CureVac Sign Manufacturing Contract For CureVac's Covid-19 Vaccine Candidate

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CureVac BV

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Industry

Biotechnology & Drugs

Contact Info

Friedrich-Miescher-Str. 15

72076

Germany

+49.7071.98830

Key Stats

2.00 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2020(E)

0.1K
EPS (EUR)

2020(E)

-2.513
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
19.74
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
4.03
LT Debt To Equity (MRQ)
3.64
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up